Viewing Study NCT00436995


Ignite Creation Date: 2025-12-24 @ 1:33 PM
Ignite Modification Date: 2026-02-01 @ 11:13 PM
Study NCT ID: NCT00436995
Status: COMPLETED
Last Update Posted: 2011-01-21
First Post: 2007-02-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving Dialysis
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Kidney Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dialysis View
None Anaemia View